Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.
Olbertova H, Plevova K, Pavlova S, Malcikova J, Kotaskova J, Stranska K, Spunarova M, Trbusek M, Navrkalova V, Dvorackova B, Tom N, Pal K, Jarosova M, Brychtova Y, Panovska A, Doubek M, Pospisilova S.
Olbertova H, et al. Among authors: navrkalova v.
BMC Cancer. 2022 Feb 3;22(1):137. doi: 10.1186/s12885-022-09221-z.
BMC Cancer. 2022.
PMID: 35114947
Free PMC article.